Research tools company sought to leverage their platform technology to identify novel immunoregulatory receptor targets for new therapeutic development beyond current known checkpoint inhibitors.
Approach & Deliverables
- Completed a landscape analysis of the immunoregulatory field and current market
- Analyzed core technology, IP position, and competitive position
- Validated the value-proposition of the technology through primary interviews with key scientific and industry leaders
- Outlined the requirements and necessary datasets to achieve corporate partnership interest
- Identified and made introductions to potential strategic partners or customers for this asset